Abstract
The group of indications regarding benign tumors and organoid nevi is very heterogeneous. Ablative lasers (CO2 and Erbium:YAG laser) are mainly used for therapy. In case there is an additional vascular component, the (additional) use of vascular specific lasers makes sense (long-pulsed Nd:YAG and dye laser). The recurrence rates are often not negligible. Sufficient sun protection is especially important after deeper ablations. Pretherapeutic biopsies are important.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams BB, Mutasim DF, Nordlund JJ. Steatocystoma multiplex: a quick removal technique. Cutis. 1999;64:127–30.
Alster TS. Inflammatory linear verrucous epidermal nevus: successful treatment with the 585 nm flashlamp-pumped pulsed dye laser. J Am Acad Dermatol. 1994;31:513–4.
Alster TS, West TB. Ultrapulse CO2 laser ablation of xanthelasma. J Am Acad Dermatol. 1996;34:848–9.
Apfelberg DB, Maser MR, Lash H, White DN. Treatment of xanthelasma palpebrarum with the carbon dioxide laser. J Dermatol Surg Oncol. 1987;13:149–51.
Apfelberg DB, Maser MR, Lash H, White H, Cosman B. Superpulse CO2 laser treatment of facial syringomas. Lasers Surg Med. 1987;7:533–7.
Arndt KA. Adenoma sebaceum: successful treatment with the argon laser. Plast Reconstr Surg. 1982;70:91–3.
Ashinoff R. Linear nevus sebaceus of Jadassohn treated with the carbon dioxide laser. Pediatr Dermatol. 1993;10:189–91.
Baba T, Narumi H, Hanada K, Hashimoto I. Successful treatment of dark-colored epidermal nevus with ruby laser. J Dermatol. 1995;22:567–70.
Becker DW. Use of the carbon dioxide laser in treating multiple cutaneous neurofibromas. Ann Plast Surg. 1991;26:582–6.
Berlin AL, Billick RC. Use of CO2 laser in the treatment of periungual fibromas associated with tuberous sclerosis. Dermatol Surg. 2002;28(5):434–6.
Birt AR, Hogg GR, Dubé WJ. Multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol. 1977;113:1674–7.
Bohigian RK, Shapshay SM, Hybels RL. Management of rhinophyma with carbon dioxide laser: Lahey clinic experience. Lasers Surg Med. 1988;8:397–401.
Boixeda P, Sanchez-Miralles E, Azana JM, Arrazola JM, Moreno R, Ledo A. CO2, argon, and pulsed dye laser treatment of angiofibromas. J Dermatol Surg Oncol. 1994;20:808–12.
Castro DJ, Soudant J, Saxton RE. The surgical management of facial syringomas using the superpulsed CO2-Laser. J Clin Laser Med Surg. 1993;11:33–7.
Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceus: a study of 596 cases. J Am Acad Dermatol. 2000;42:263–8.
Dmovsek-Olup B, Vedlin B. Use of the Er:YAG laser for benign skin disorders. Lasers Surg Med. 1997;21:13–9.
Drosner M, Vogt HJ. Xanthelasma palpebrarum. Behandlung mit dem Argonlaser Z Hautkr. 1991;67:144–7.
Ellis DL. Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser. Dermatol Surg. 1996;22:33–7.
Fitzpatrick RE, Goldman MP, Ruiz-Esparza J. Clinical advantage of the CO2 laser superpulsed mode. Treatment of verruca vulgaris, seborrheic keratoses, lentigines, and actinic cheilitis. Dermatol Surg Oncol. 1994;20:449–56.
Flores JT, Apfelberg DB, Maser MR, Lash H. Trichoepithelioma: successful treatment with the argon laser. Plast Reconstr Surg. 1984;74:694–8.
Foucar K, Rosen T, Foucar E, Cochran RJ. Fibrofolliculoma: a clinicopathologic study. Cutis. 1981;28:429–32.
Frame JW. Carbon dioxide laser surgery for benign oral lesions. Br Dent J. 1985;158:125–8.
Frame JW. Removal of oral soft tissue pathology with the CO2 laser. J Oral Maxillofac Surg. 1985;43:850–5.
Gambichler T, Wolter M, Altmeyer P, Hoffman K. Treatment of Birt-Hogg-Dubé syndrome with erbium:YAG laser. J Am Acad Dermatol. 2000;43(5 Pt 1):856–8.
Giroux JM, Cadotte M, Barolet D, Provost N. Fibrofolliculoma. Treatment with copper vapor laser. Ann Dermatol Venereol. 1994;121(2):130–3.
Gjuric M, Rettinger G. Comparison of carbon dioxide laser and electrosurgery in the treatment of rhinophyma. Rhinology. 1993;31:37–9.
Gladstone GJ, Beckman H, Elson LM. CO2 laser excision of xanthelasma lesions. Arch Ophthalmol. 1985;103:440–2.
Gonzalez S, White WM, Rajadhyaksha M, Anderson RR, Gonzalez E. Confocal imaging of sebaceous gland hyperplasia in vivo to assess efficacy and mechanism of pulsed dye laser treatment. Lasers Surg Med. 1999;25:8–12.
Greenbaum SS, Krull EA, Watnick K. Comparison of CO2 laser and electrosurgery in the treatment of rhinophyma. J Am Acad Dermatol. 1988;18:363–8.
Hadshiew I, Wetzel F, Kimmig W. Treatment of urticaria pigmentosa lesions with the Q-switched ruby-laser. Aust J Dermatol. 1997;38(suppl 2):51–2.
Hammes S, Raulin C, Karsai S, Bernt R, Ockenfels HM. Management papillomatöser intradermaler Nävi: Laser ja oder nein? Eine Prospektivstudie. Hautarzt. 2008;59(2):101–7.
Har-El G, Shapshay SM, Bohigian RK, Krespi YP, Lucente FE. The treatment of rhinophyma. ‘Cold’ vs laser techniques. Arch Otolaryngol Head Neck Surg. 1993;119:628–31.
Hartmann A, Bauer C, Haferkamp B, Lurz C, Hamm H, Bröcker EB. Dermablation benigner Neubildungen sowie Präkanzerosen der Haut mit dem Er:YAG-Laser. Hautarzt 1999;50(suppl 1):139.
Hellwig S, Petzoldt D, König K, Raulin C. Aktueller Stand der Lasertherapie in der Dermatologie. Hautarzt. 1998;49:690–704.
Hintschich C. Argonlaserkoagulation von Xanthelasmen. Ophthalmologe. 1995;92:858–61.
Hoffman SJ, Walsh P, Morelli JG. Treatment of angiofibroma with the pulsed tunable dye laser. J Am Acad Dermatol. 1993;29:790–1.
Hohenleutner U, Landthaler M. Laser therapy of verrucous epidermal naevi. Clin Exp Dermatol. 1993;18:124–7.
Hohenleutner U, Wlotzke U, Konz B, Landthaler M. Carbon dioxide laser therapy of a widespread epidermal nevus. Lasers Surg Med. 1995;16:288–91.
Huerter CJ, Wheeland RG. Multiple eruptive vellus hair cysts treated with carbon dioxide laser vaporization. J Dermatol Surg Oncol. 1987;13:260–3.
Jacob CI, Dover JS. Birt-Hogg-Dube syndrome: treatment of cutaneous manifestations with laser skin resurfacing. Arch Dermatol. 2001;137(1):98–9.
Janniger CK, Goldberg DJ. Angiofibromas in tuberous sclerosis: comparison of treatment by carbon dioxide and argon laser. J Dermatol Surg Oncol. 1990;16:317–20.
Jozwiak S, Schwartz RA, Janninger CK, et al. Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance. Int J Dermatol. 1998;37:911–7.
Junkins-Hopkins JM, Cooper PH. Multiple perifollicular fibromas: report of a case and analysis of the literature. J Cutan Pathol. 1994;21:467–71.
Kahle B, Hellwig S, Schulz T. Multiple mantleomas in Birt-Hogg-Dubé syndrome: successful therapy with CO2 laser. Hautarzt. 2001;52(1):43–6.
Kardorff B. Neurofibromatose Typ I (Morbus Recklinghausen): Kombinierte Erbium:YAG-Laser- und Exzisionstherapie von kutanen Neurofibromen. Derm. 1998;4:404–6.
Kardorff B, Kunze J. Neurofibromatose Typ I (Morbus Recklinghausen): Erbium:YAG-Lasertherapie von kutanen Neurofibromen – Nachbeobachtung über ein Jahr. Derm. 1999;5:199–200.
Karim Ali M, Streitmann MJ. Excision of rhinophyma with the carbon dioxide laser: a ten-year experience. Ann Otol Rhinol Laryngol. 1997;106:952–5.
Karrer S, Hohenleutner U, Szeimies RM, Landthaler M. Treatment of digital mucous cysts with a carbon dioxide laser. Acta Derm Venereol. 1999;79:224–5.
Karsai S, Czarnecka A, Raulin C. Treatment of xanthelasma palpebrarum with a pulsed dye laser: a prospective clinical trial in 38 cases. Dermatol Surg. 36:610–17.
Karsai S, Schmitt L, Raulin C. Is Q-switched Nd:YAG laser (532 nm and 1064 nm) an effective approach to treat xanthelasma palpebrarum? Results from a clinical study in 76 cases. Dermatol Surg. 2009 Dec;35(12):1962-9.
Katalinic D. Laser surgery of Neurofibromatosis 1 (NF 1). J Clin Laser Med Surg. 1992;10:185–92.
Kaufmann R, Hibst R. Pulsed Erbium:YAG laser ablation in cutaneous surgery. Lasers Surg Med. 1996;19:324–30.
Kint A, Baran R. Histopathologic study of Koenen tumors. Are they different from acquired digital fibrokeratoma? J Am Acad Dermatol. 1988;18:369–72.
Krahenbuhl A, Eichmann A, Pfaltz M. CO2 laser therapy for steatocystoma multiplex. Dermatologica. 1991;183:294–6.
Landthaler M, Hohenleutner U. Benigne Tumoren. In: Lasertherapie in der Dermatologie. Lehrbuch und Atlas. Landthaler M, Hohenleutner U, Hrsg. 1. Auflage. Berlin: Springer;1999.p. 97–102.
Landthaler M, Hohenleutner U. Benigne Tumoren. In: Lasertherapie in der Dermatologie. Atlas und Lehrbuch. Landthaler M, Hohenleutner U, Hrsg. 1. Auflage. Berlin: Springer; 1999. p. 99–100.
Losee JE, Serletti JM, Pennino RP. Epidermal nevus syndrome: a review and case report. Ann Plast Surg. 1999;43:211–4.
Luomanen M. Experience with a carbon dioxide laser for removal of benign oral soft-tissue lesions. Proc Finn Dent Soc. 1992;88:49–55.
Mazaira M, del Pozo LJ, Fernández-Jorge B, Fernández-Torres R, MartÃnez W, Fonseca E. Shave and phenolization of periungual fibromas, Koenen’s tumors, in a patient with tuberous sclerosis. Dermatol Surg. 2008;34(1):111–3.
Mendelson BC, Maason JK. Xanthelasma: follow-up or results after surgical excision. Plast Reconstr Surg. 1976;58:535–8.
Nammour S, Dourov N. Removal of benign tumors using the CO2 laser. J Clin Laser Med Surg. 1992;10:109–13.
Neumann RA, Knobler RM. Treatment of oral mucous cysts with an argon laser. Arch Dermatol. 1990;126:829–30.
Nickel WR, Reed WB. Tuberous sclerosis. Arch Dermatol. 1962;85:209–26.
Olbricht SM. Use of the carbon dioxide laser in dermatologic surgery. A clinically relevant update for 1993. J Dermatol Surg Oncol. 1993;19:364–9.
Pick RM, Colvard MD. Current status of lasers in soft tissue dental surgery. J Periodontol. 1993;64:589–602.
Pick RM, Pecaro BC. Use of the CO2 laser in soft tissue dental surgery. Lasers Surg Med. 1987;7:207–13.
Ratz JL, Bailin PL, Wheeland RG. Carbon dioxide laser treatment of epidermal nevi. J Dermatol Surg Oncol. 1986;12:567–70.
Raulin C, Greve B. Laser und IPL-Technologie in der Dermatologie und Ästhetischen Medizin. Stuttgart: Schattauer; 2003.
Raulin C, Schönermark MP, Greve B, Werner S. Q-switched ruby laser treatment of tattoos and benign pigmented skin lesions: a critical review. Ann Plast Surg. 1998;41:555–65.
Raulin C, Schönermark MP, Werner S, Greve B. Xanthelasma palpebrarum: treatment with the ultrapulsed CO2 laser. Lasers Surg Med. 1999;24:122–7.
Richter W. Die Anwendung eines Kohlendioxid Lasers bei der Behandlung oraler Weichgewebe. ZWR. 1990;99:969–76.
Riedel F, Bergler W, Baker-Schreyer A, Stein E, Hörmann K. Kontrollierte Feinstdermablation im Gesichtsbereich mit dem Erbium:YAG-Laser. HNO. 1999;47:101–6.
Riedel F, Kanafani N, Windberger J, Stein E. Entfernung von Syringomen mit dem Erbium:YAG Laser-System. Akt Dermatol. 1998;24:20–2.
Roenigk RK, Ratz JL. CO2 laser treatment of cutaneous neurofibromas. J Dermatol Surg Oncol. 1987;13:187–90.
Rongioletti F, Hazini R, Gianotti G, Rebora A. Fibrofolliculomas, trichodiscomas and acrochordons (Birt-Hogg-Dubé) associated with intestinal polyposis. Clin Exp Dermatol. 1988;14:72–4.
Sajben FP, Ross EV. The use of the 1.0 mm handpiece in high energy, pulsed CO2 laser destruction of facial adnexal tumors. Dermatol Surg. 1999;25:41–4.
Sawchuk WS, Heald PW. CO2 laser treatment of trichoepithelioma with focused and defocused beam. J Dermatol Surg Oncol. 1984;10:905–7.
Schönermark MP, Raulin C. Treatment of xanthelasma palpebrarum with the pulsed dye laser. Lasers Surg Med. 1996;19:336–9.
Schönermark MP, Schmidt C, Raulin C. Treatment of sebaceous gland hyperplasia with the pulsed dye laser. Lasers Surg Med. 1997;21:313–6.
Shapshay SM, Strong MS, Anastasi GW, Vaughan CW. Removal of rhinophyma with the carbon dioxide laser: a preliminary report. Arch Otolaryngol. 1980;106:257–9.
Song MG, Park KB, Lee ES. Resurfacing of facial angiofibromas in tuberous sclerosis patients using CO2 laser with flashscanner. Dermatol Surg. 1999;25:970–3.
Spenler CW, Achauer BM, Vander Kam VM. Treatment of extensive adenoma sebaceum with a carbon dioxide laser. Ann Plast Surg. 1988;20:586–9.
Tanzi E, Alster TS. Pulsed dye laser treatment of multiple eccrine hidrocystomas: a novel approach. Dermatol Surg. 2001;27:898–900.
Ullmann Y, Har-Shai Y, Peled IJ. The use of CO2 laser for the treatment of xanthelasma palpebrarum. Ann Plast Surg. 1993;31:504–7.
Wang JI, Roenigk HH. Treatment of multiple facial syringomas with the carbon dioxide (CO2) laser. Dermatol Surg. 1999;25:136–9.
Ward PE, McCarthy DJ. Periungual fibroma. Cutis. 1990;46:118–24.
Werner S, Hellwig S, Raulin C. Behandlung seborrhoischer Keratosen mit dem gütegeschalteten Rubinlaser. Akt Dermatol. 1996;22:207–9.
Werner S, Raulin C. Behandlung von Syringomen mit dem ultragepulsten CO2-Laser. Z Hautkr. 1996;71:760–2.
Weston J, Apfelberg DB, Maser MR, Lash H, White D. Carbon dioxide laserabrasion for treatment of adenoma sebaceum in tuberous sclerosis. Ann Plast Surg. 1985;15:132–7.
Wheeland RG, Bailin PL, Kronberg E. Carbon dioxide (CO2) laser vaporization for the treatment of multiple trichoepithelioma. J Dermatol Surg Oncol. 1984;10:470–5.
Wheeland RG, Bailin PL, Ratz JL. Combined carbon dioxide laser excision and vaporization in the treatment of rhinophyma. J Dermatol Surg Oncol. 1987;13:172–7.
Aknowledgement:
I would like to thank Alexandra Hammes for translating this chapter into English and for proofreading.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hammes, S. (2011). Benign Tumors and Organoid Nevi. In: Raulin, C., Karsai, S. (eds) Laser and IPL Technology in Dermatology and Aesthetic Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-03438-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-03438-1_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-03437-4
Online ISBN: 978-3-642-03438-1
eBook Packages: MedicineMedicine (R0)